Table 2 CE data/statistics
From: Cost-utility of tiotropium in patients with severe asthma
Threshold (US$ per QALY) | 5180 |
Intervention | Tiotropium + ICS + LABA |
Comparator | ICS + LABA |
Number of PSA runs | 10,000 |
Mean incremental. Effect per person (QALY) | 0.0018 |
Mean incremental. Cost per person (US$) | −4.65 |
ICER estimate (US$ per QALY) | −2637.59 |
2.5th centile for inc. effects (QALY) | −0.048 |
97.5th centile for inc. effects (QALY) | 0.018 |
2.5th centile for inc. costs (US$) | −34.44 |
97.5th centile for inc. costs (US$) | 11.07 |
Probability intervention is cost saving | 0.66 |
Probability intervention provides more benefit | 0.76 |
Probability that intervention is cost-effective against comparator | 0.77 |